Published in

MDPI, International Journal of Molecular Sciences, 23(20), p. 5867, 2019

DOI: 10.3390/ijms20235867



Export citation

Search in Google Scholar

Osteoporosis in Rheumatic Diseases

Journal article published in 2019 by Adami ORCID, Fassio, Rossini, Caimmi ORCID, Giollo, Orsolini, Viapiana, Gatti
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO


Osteoporosis is a chronic disease characterized by an increased risk of fragility fracture. Patients affected by rheumatic diseases are at greater risk of developing osteoporosis. The purpose of the present review is to discuss the pathogenesis, epidemiology, and treatment of osteoporosis in patients affected by rheumatic diseases with special focus for rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, systemic lupus erythematosus, systemic sclerosis, vasculitides, Sjogren syndrome, and crystal-induced arthritis.